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The nuclear hormone receptor (NR) superfamily includes the orphan NR4A subgroup, comprised of Nur77
(NR4A1), Nurr1 (NR4A2) and NOR-1 (NR4A3).These NRs are classified as early response genes, are induced
by a diverse range of signals, including fatty acids, stress, growth factors, cytokines, peptide hormones,
phorbol esters, neurotransmitters, and physical stimuli (for example magnetic fields, shear stress).The ability
to sense and rapidly respond to changes in the cellular environment thus appears to be a hallmark of this
subfamily.The members of the NR4A subgroup are well conserved in the DNA binding domain (~91-95%) and
the C-terminal ligand-binding domain (~60%), but are divergent in the N-terminal AB region.These receptors
bind as monomers, homodimers and heterodimers with RXRs (to mediate retinoid signaling) to different
permutations of the canonical NR binding motif.The NR4A subgroup activates gene expression in a constitutive
ligand-independent manner. NR4A-mediated trans-activation (LBD) involves unusually active N-terminal AF-1
domains that mediate coactivator recruitment. Moreover, the NR4A receptors encode atypical LBDs and AF-2
domains. For example, the LBDs contain no cavity due to bulky hydrophobic residue side chains, and lack
the classical coactivator-binding cleft constituted by helices 3, 4 and 12. However, a hydrophobic patch exists
between helices 11 and 12, that encodes a novel cofactor interface that modulates transcriptional activity. In
line with the pleiotropic physiological stimuli that induce the NR4A subgroup, these orphan NRs have been
implicated in cell cycle regulation (and apoptosis), neurological disease, steroidogenesis, inflammation,
carcinogenesis and atherogenesis.
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NR4A orphan nuclear receptors
NR4A1 (Nur77, TR3, NGFI-B, N10, DHR38, NAK-1, TIS1)
[Hazel et al., 1988; Milbrandt, 1988], NR4A2 (Nurr1,
HZF-3, RNR-1, TINUR, NOT) [Law et al., 1992] and
NR4A3 (NOR-1, TEC, MINOR, CHN) [Ohkura et al., 1996]
comprise the NR4A subgroup of orphan nuclear
receptors.The members of the NR4A subgroup are
expressed in a wide variety of metabolically demanding
and energy dependent tissues, such as skeletal muscle,
adipose, heart, kidney, T-cells, liver and the brain
[Arkenbout et al., 2002; Lim et al., 1995; Nakai et al.,
1990;Winoto, 1997; Zetterstrom et al., 1996].The NR4A
subfamily of NRs activate gene expression in a
constitutive ligand-independent manner [Davis et al.,
1993; Maltais and Labelle, 2000; Paulsen et al., 1992;
Paulsen et al., 1995].The binding site for the NR4A
receptors is the octanucleotide 5’-A/TAAAGGTCA
(NGFI-B response element, NBRE; Fig. 1A) [Wilson et
al., 1992;Wilson et al., 1991;Wilson et al., 1993b], and
they can bind as monomers [Paulsen et al., 1995] and
homodimers [Maira et al., 1999; Philips et al., 1997].The
transcriptional target of NR4A homodimers, called the
Nur-responsive element (NurRE; Fig. 1B), is an everted
repeat of the NBRE-related octanucleotide,
AAAT(G/A)(C/T)CA, and this motif is found naturally
occurring in the pro-opiomelanocortin (POMC) gene
promoter [Philips et al., 1997]. Nur77 and Nurr1 (but not
NOR-1) can also bind as heterodimers with RXR to
mediate retinoid signaling [Perlmann and Jansson, 1995;
Zetterstrom et al., 1996].These RXR heterodimers bind
a motif called DR5 (Fig. 1C), comprised of two direct
repeats of the consensus NR binding motif separated by
five nucleotides [Perlmann and Jansson, 1995].
Furthermore, heterodimers can also be formed between
members of the subgroup [Maira et al., 1999] (Fig 1B).
Figure 1.  NR4A response elements. The NR4A family members
can bind as monomers to the NBRE (panel A), homodimers and NR4A
heterodimers to the NurRE (panel B), or heterodimers with RXR to the
DR5 motif (panel C).The naturally occurring NurRE from the
pro-opiomelanocortin (POMC) promoter is shown.
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from a common ancestral gene, as the genomic structures
for these receptors are extremely similar
[Saucedo-Cardenas et al., 1997].The members of the
NR4A subgroup are well conserved in the DNA binding
domain (~91-95%) and the C-terminal ligand-binding
domain (LBD) (~60%), but are divergent in the N-terminal
AB region [Murphy et al., 1996; Paulsen et al., 1995;
Saucedo-Cardenas et al., 1997]. In the classical model
of NR regulation, a hydrophobic cleft in the LBD recruits
cofactors that function as coactivators or corepressors of
transcription. However, the NR4A receptors encode
unusual and atypical LBDs, which do not function in a
classical manner [Paulsen et al., 1992]. However, it has
been demonstrated that the LBD of Nurr1 (and to a lesser
extent, NOR-1) can activate transcription, but this
activation is not observed in all cell types [Castro et al.,
1999]. Interestingly, it has been reported that
NR4A-mediated transcription and cofactor recruitment
also involves the N-terminal AF-1 domain [Castro et al.,
1999; Maira et al., 2003;Wansa et al., 2002;Wansa et
al., 2003]. In this context, phosphorylation of serine 105
in the N-terminal AF-1 domain has been implicated in
growth factor dependent nucleo-cytoplasmic shuttling of
Nur77 [Kang et al., 2000]. In summary, the NR4A
subgroup encodes atypical NRs with very potent AF-1
domains, and LBDs with unique structures and regulatory
properties.
NR4A genes encode atypical LBDs
This receptor subgroup initially proved refractory to the
understanding of LBD mediated coactivator recruitment
in the context of constitutive agonist independent
trans-activation [Castro et al., 1999]. Moreover, the NR4A
LBDs lack intrinsic and classical activation domains;
nevertheless, site-specific mutations and deletions in helix
12 compromise the activity of this unique subgroup of
orphan receptors [Paulsen et al., 1992]. Molecular
modelling studies demonstrated that the LBDs of the
NR4A1 and 3 receptors encode unusually hydrophilic
surfaces with unique topography, rather than the classical
hydrophobic cleft that mediates steroid receptor
coactivator (SRC) recruitment [Wansa et al., 2002;Wansa
et al., 2003]. Subsequently, X-ray crystallography studies
demonstrated that the LBD of the orphan NR4A2 (Nurr1)
adopts a canonical fold resembling that of agonist
activated LBDs [Wang et al., 2003].This is reminiscent
of modelling studies with RORα that demonstrated the
AF2 domain is locked permanently in the
holo-conformation described for other liganded receptors,
and thus enables ligand independent recruitment of
coactivators [Harris et al., 2002].The Nurr1 LBD had two
distinctive features. Firstly, the Nurr1 LBD lacks a cavity
as a result of bulky side chains from hydrophobic residues
in the region normally occupied by agonists [Wang et al.,
2003].This is very similar conclusion to modelling studies
from Renaud and coworkers, that showed the Rev-erb α
and β encode LBDs occupied by bulky side chains
[Renaud et al., 2000].The crystal studies rigorously
concluded that Nurr1 lacked a classical binding site for
coactivators and polar side chains occupy the classical
cleft [Wang et al., 2003]. Similar X-ray crystal studies on
DHR38, the Drosophila ortholog of mammalian NR4A1,
in the same way revealed the absence of a classic ligand
binding pocket and classical coactivator binding site,
features common to all the NR4A subgroup [Baker et al.,
2003]. Recent crystal and NMR studies identified a
hydrophobic patch between helices 11 and 12 that
interacts with cofactors and modulates transcriptional
activity [Codina et al., 2004; Flaig et al., 2005].
The NR4A receptors respond to diverse
stimuli
The NR4A subgroup are immediate early or stress
response genes, and can be induced by a wide range of
physiological signals (see Fig. 2), such as fatty acids,
stress, prostaglandins, growth factors, calcium,
inflammatory cytokines, peptide hormones, phorbol
esters, and neurotransmitters [Borghaei et al., 1998;
Fahrner et al., 1990; Hazel et al., 1988; Honkaniemi et
al., 1994; Honkaniemi et al., 2000; Kagaya et al., 2005;
Katagiri et al., 1997; Roche et al., 1999;Tetradis et al.,
2001a;Tetradis et al., 2001b;Tippetts et al., 1988;
Williams and Lau, 1993]. Physical stimuli - for example
magnetic fields, mechanical agitation (causing fluid shear
stress), and membrane depolarization [Bandoh et al.,
1997; Hazel et al., 1991; Katagiri et al., 1997; Miyakoshi
et al., 1998] - have also been shown to induce expression
of the NR4A receptors.The ability to sense and rapidly
respond to changes in the cellular environment thus
appears to be a hallmark of this subfamily of orphan
nuclear receptors.
Figure 2.  Diverse stimuli induce the NR4A subgroup. Nur77,
NOR-1 and Nurr1, immediate early response genes that sense and
respond to changes in the cellular environment, are induced by
physiological and physical stimuli.
NR4A function in the central nervous
system
There is widespread expression of all three NR4A
receptors in the central nervous system [Zetterstrom et
al., 1996], including the dopaminergic neurons. Nurr1
plays a role in the transcriptional activation of tyrosine
hydroxylase (an enzyme involved in the synthesis of
dopamine) [Sakurada et al., 1999], and is essential for
the development of dopaminergic neurons in the midbrain
[Zetterstrom et al., 1997]. Nurr1 mutations have also been
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Anti-psychotic drugs can induce NOR-1, but the role of
NOR-1 may be distinct from Nur77 in the dopamine
receptor signaling response to these drugs, possibly due
to the inability of NOR-1 to form heterodimers with RXR
[Maheux et al., 2005]. Anti-psychotic drugs can also
induce Nur77 [Beaudry et al., 2000]. Knockout mouse
studies of the NR4A members have provided particularly
useful insights into the role of the subfamily in the central
nervous system.
NR4A receptors, steroidogenesis and
inflammation
Activation of the HPA axis starts with the secretion of
hypothalamic corticotropin releasing hormone (CRH),
followed by the activation of pituitary POMC gene
transcription and adrenocorticotropic hormone (ACTH)
secretion in response to CRH, resulting in ACTH-induced
stimulation of adrenal glucocorticoid synthesis. NOR-1,
Nur77 and NURR1 have been shown to play a key role
in regulating expression of various genes in the HPA axis
related to inflammation and steroidogenesis [Crawford et
al., 1995; Fernandez et al., 2000; Stocco et al., 2002].
Furthermore, transcriptional antagonism between the
glucocorticoid receptor and the NR4A subgroup has been
described for many years [Martens et al., 2005]. CRH
treatment of adrenal and pituitary cells induces Nur77
[Philips et al., 1997], and Nur77 activates expression of
CRH [Murphy et al., 2001].These events lead to the
activation of the gene encoding steroid 21α-hydroxlylase
[Davis and Lau, 1994;Wilson et al., 1993a].The NR4A
subfamily also regulates steroid 17-hydroxylase and the
20α-hydroxysteroid dehydrogenase promoters [Davis
and Lau, 1994; Stocco et al., 2000;Wilson et al., 1993a].
In response to CRH, the NR4A subfamily enhances the
gene expression of POMC, the precursor to ACTH (the
chief regulator of adrenal steroidogenesis and CRH
[Murphy and Conneely, 1997; Murphy et al., 1996; Philips
et al., 1997]. In response to inflammatory cytokines (e.g
IL-1β, TNF-α) there is local up-regulation of CRH in
rheumatoid arthritis synovial tissue, indicating CRH as a
component of the inflammatory cascade in arthritis
[Murphy et al., 2001].
The NR4A subfamily has been extensively investigated
in the context of inflammation.Two recent studies have
shown that Nur77, NOR-1 and Nurr1 are rapidly induced
in macrophages following lipopolysaccharide (LPS)
stimulation [Barish et al., 2005; Pei et al., 2005], and that
treatment with oxidised lipids and various cytokines can
also stimulate Nur77 induction [Pei et al., 2005].
Interestingly, IFNγ also induced the expression of the
NR4A subfamily in macrophages, but the induction was
delayed compared to LPS, peaking at 16 to 24 hours after
IFNγ exposure. In addition, the latter study showed a link
between the NR4A response and the NF-κB signaling
pathway [Pei et al., 2005]. Nur77 and Nurr1 are similarly
induced in response to inflammatory cytokines in
rheumatoid arthritis [Murphy et al., 2001].TNFα
upregulates the expression of Nur77 in human umbilical
vein endothelial cells, and in turn, the PAI-1 (plasminogen
activator inhibitor 1) promoter contains a Nur77 binding
region that mediates the TNFα induction of PAI-1 [Gruber
et al., 2003]. High plasma levels of PAI-1 have been
linked to increased risk of vascular diseases, and Nur77
and PAI-1 co-localise in atherosclerotic vessels [Gruber
et al., 2003]. Interestingly, it has recently been shown
that the thiazolidinediones rosiglitazone and pioglitazone
attenuate the induction of Nur77 (and Nurr1) in endothelial
cells stimulated with TNFα [Liu et al., 2005].The complex
and diverse role of the NR4A members, in particular the
involvement of Nur77 in modulating apoptosis in the
inflammatory response, continues to be investigated.
NR4A receptors in smooth muscle cells
and atherogenesis
The NR4A subgroup is expressed in multiple human
atherosclerotic lesions from type II to V stages of
atherosclerosis [Arkenbout et al., 2002].The three
members of the subgroup are expressed in neointimal
(but not medial) smooth muscle cells (SMCs) [Arkenbout
et al., 2003]. Moreover, the NOR-1 (NR4A3) gene is a
target of the cAMP responsive element binding
protein-mediated mitogenic effects of low-density
lipoprotein (LDL) on vascular SMCs. Inhibition of NR4A3
expression inhibits the LDL induced proliferation [Rius et
al., 2004]. Furthermore, emerging evidence demonstrates
in a ‘carotid artery ligation induced SMC proliferation
mouse model’ that NR4A1 inhibition results in increased
neointimal formation, whereas neointimal formation is
inhibited in transgenic mice expressing full length NR4A1.
The process involves the NR4A1 mediated increase in
the synthesis of the cyclin dependent kinase inhibitor,
p27 (kip1) [Arkenbout et al., 2002]. In conclusion, this will
require further investigation to resolve the role of the
NR4A subgroup in atherosclerosis. For example, the link
between PAI-1, Nur77, and vascular disease has to be
reconciled in the context of Nur77 expression in
neointimal formation.
NR4A null mutants: functional
redundancy?
Interestingly, despite the dynamic role of Nur77 in the
regulation of gene expression in the
hypothalamic-pituitary-adrenal (HPA) axis, there is normal
basal regulation of the hypothalamic and pituitary
systems, and steroidogenesis in Nur77-/- mice [Crawford
et al., 1995]. Nurr1 and NOR-1 have also been shown to
be involved in HPA function [Fernandez et al., 2000;
Murphy et al., 2001], raising the possibility that the
Nur77-/- mice are rescued by compensatory expression
of the other NR4A subfamily members. Along these lines,
Nur77 mediates T cell receptor mediated T cell apoptosis
[Liu et al., 1994;Woronicz et al., 1994;Woronicz et al.,
1995], however, Nur77-/- mice do not have dysfunctional
thymic and peripheral T cell death. Again this can be
accounted for by functional redundancy in the subgroup,
for example, NOR-1 also has pro-apoptotic activity in
thymocytes [Cheng et al., 1997; Lee et al., 1995].
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Review NR4A subgroupFigure 3.  Organ and tissue specific effects of the NR4A subgroup. Schematic summarising the pleiotropic, cell-specific effects of this NR
subgroup, that function as immediate early response genes in a variety of pathophysiological conditions.
Nurr1-/- mice develop to full-term [Castillo et al., 1998].
However, neonates die at birth, apparently due to a
severe defect in respiratory function [Nsegbe et al., 2004].
Nurr1 ablation leads to selective agenesis of midbrain
dopaminergic neurons [Saucedo-Cardenas et al., 1998;
Zetterstrom et al., 1997].The homozygous and
heterozygous mice lack (or have substantially reduced
levels of) dopamine in the brain, consistent with the
absence of tyrosine hydroxylase, L-aromatic amino
decarboxylase and other dopamine neuronal markers
[Castillo et al., 1998]. Recently, it has been demonstrated
that Nurr1 is required for the neurotransmitter identity of
ventral midbrain dopaminergic neurons, and Nurr1
expression is also required for the induction of the
vesicular monoamine transporter 2 and dopamine
transporter expression [Smits et al., 2003]. Furthermore,
a recent report has established that decreased Nurr1
expression results in the increased vulnerability of
dopaminergic neurons to dopaminergic toxins.This
cascade involves nitric oxide, increased expression of
nitric oxide synthase and 3-nitrotyrosine in the striatum
of heterozygous Nurr1+/- mice. Moreover, induction of
Caspase-3 and p53, and reduced expression of Bcl-2
were also observed [Imam et al., 2005].
NOR-1 null mice have inner ear defects, and impaired
bi-directional circling behavior associated with diminished
endolymphatic fluid space in the canals.This is
concordant with NOR-1 expression in the semi-circular
canal forming fusion plates, and the non-sensory epithelial
cells [Ponnio et al., 2002; Ponnio and Conneely, 2004].
Furthermore, the NOR-1 -/- mice are sensitive to
excitotoxic glutamate receptor agonists and display
increased limbic seizure activity.This phenotype is
associated with impaired postnatal hippocampal
development, abnormal axon guidance and postnatal
death of hippocampal pyramidal neurons [Ponnio and
Conneely, 2004].
In summary, the phenotypes reported for NR4A null
mutants are consistent with central nervous system
expression and function, but analysis of the many other
reported roles of these immediate early genes is
complicated by functional redundancy. Hopefully, future
analysis of double and triple knockouts, and/or
tissue-specific NR4A attenuation will provide further
insights into the pleiotropic functions of these receptors.
NR4A receptors and cancer
Chimeric fusions of NOR-1 with EWS [Clark et al., 1996;
Labelle et al., 1999], TCF12 [Sjogren et al., 2000] and
TAF2N [Attwooll et al., 1999; Panagopoulos et al., 1999;
Sjogren et al., 1999] have been linked to extraskeletal
myxoid chondrosarcoma. Furthermore, the role of the
NR4A subfamily members in cancer is also largely defined
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apoptosis. Apoptosis in many tumor types, including
colon, breast, prostate, lung, and gastric cancers, have
been shown to involve the NR4A family members [Li et
al., 1998; Ohkubo et al., 2000;Wilson et al., 2003;Wu et
al., 2002; Zhang, 2002]. Ongoing research continues to
define the precise role of the NR4A subgroup in cell cycle
regulation.
The NR4A receptors in metabolism
Previous reports described the induction of Nur77 by
adrenergic agonists in muscle [Lim et al., 1995], and brain
[Bing et al., 1991]; however, these isolated reports had
not been reproduced. A recent study demonstrated that
Nur77 mRNA is rapidly and transiently induced in C2C12
skeletal muscle cells by isoprenaline (a general
β-adrenergic receptor agonist) [Maxwell et al., 2005].
These studies also showed that siRNA-mediated
attenuation of Nur77 expression in C2C12 cells results
in a decrease in the mRNA and/or protein expression of
genes involved in energy expenditure and lipid
homeostasis, such as UCP3, Glut4, CD36, CAV3 and
AMPKγ3 [Maxwell et al., 2005].These findings are in
concordance with a number of recently published reports.
The coupled suppression of UCP3 and AMPKγ3 is
consistent with the activation of UCP3 in type II muscle
fibers by the AMPK activator, AICAR [Suwa et al., 2003].
Furthermore, in rat skeletal muscle L6 cells, β-adrenergic
receptor agonists increase glucose transport [Nevzorova
et al., 2002]. Interestingly, it has been reported that Nur77,
along with NOR-1 and Nurr1, are induced in skeletal
muscle during recovery from endurance exercise. Nur77
and Nurr1 are moderately increased, but strikingly, NOR-1
is highly increased under these conditions [Mahoney et
al., 2005].
In recent studies utilizing the 3T3-L1 adipocyte model,
Nur77, NOR-1 and Nurr1 are rapidly and transiently
induced by both rosiglitazone, and
dexamethasone/IBMX/insulin (DMI) induction of adipocyte
differentiation [Fu et al., 2005].The NR4A members were
induced within 2-4 hours of DMI treatment, and
expression had subsided by 12-24 hours. Interestingly,
the expression of Nur77 and NOR-1 were increased by
rosiglitazone induction of adipocyte differentiation, but
Nurr1 was not induced, and in fact exhibited decreased
expression [Fu et al., 2005].These studies in both skeletal
muscle and adipocyte systems indicate that the NR4A
subfamily has a critical role in the regulation of
metabolism, consistent with the abundant expression of
this subgroup in peripheral tissues with onerous energy
demands.
In summary, adipose tissue and skeletal muscle are major
sites of lipid and glucose metabolism, and are important
target tissues for metabolic therapies.The possibility that
modulating the activity of the NR4A subfamily may have
pharmacological application in the treatment of metabolic
disorders is supported by the observation that
β-adrenergic and PPARγ agonists, that regulate energy
expenditure, insulin sensitivity and lipid storage,
respectively, induce the expression of the NR4A family
members in these tissues.
Concluding remarks
The therapeutic utility of the subgroup (see Fig. 3) will
depend on whether reverse endocrinology, coupled to
novel chemistry, can identify small molecule regulators
(agonists, antagonists and/or selective modulators) of
this orphan NR family. X-ray crystallography studies
suggest that this will be difficult because of bulky side
chains occupying the traditional LBD cavity. Perhaps
novel small molecule regulators will be identified, that
selectively modulate the activity of this atypical NR
subgroup. For example, the anti-neoplastic compound
6-mercaptopurine has been shown to activate NOR-1
and Nurr1, in an AF-1-dependent manner, independently
of direct binding [Ordentlich et al., 2003;Wansa et al.,
2003]. Secondly, prostaglandin A2 has recently been
identified as a novel transactivator of NOR-1.The
N-terminal AF-1 domain and the LBD were both
necessary for activation. Prostaglandin A2 was also
shown to directly bind the LBD of NOR-1 [Kagaya et al.,
2005].
A very recent report suggested that E75 (the Drosophila
homolog of the orphan nuclear receptor Rev-erbα
contains a heme prosthetic group, and functions as a
redox and/or diatomic gas sensor [Reinking et al., 2005].
This exciting development and the studies above,
highlight the possibility that orphan nuclear receptors with
small ligand binding pockets may be modulated by novel
and unexpected signaling cascades.
Recent X-ray and NMR studies have identified a novel
hydrophobic patch at the C-terminal region that mediates
cofactor interaction [Codina et al., 2004; Flaig et al.,
2005], which suggests boutique peptides may be utilized
to regulate the activity of this orphan NR subgroup.There
is also the possibility that novel cofactors will be identified,
that specifically modulate the actions of the NR4A
subgroup.
The observations that this NR subgroup react as
immediate early response genes to a diverse range of
stimuli, including magnetic fields, shear stress, growth
factors, fatty acids, calcium etc, in a variety of tissues
(see Fig. 3), suggests the biomedical exploitation of this
NR subgroup will require meticulous and painstaking
studies.
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